CTOs on the Move

Catabasis

www.catabasis.com

 
At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART LinkerSM platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.catabasis.com
  • 100 High Street 28th Floor
    Boston, MA USA 02110
  • Phone: 617.349.1971

Executives

Name Title Contact Details

Funding

Catabasis raised $42M on 06/22/2018
Catabasis raised $110M on 02/08/2021

Similar Companies

Galson Laboratories

Galson Laboratories is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in East Syracuse, NY. To find more information about Galson Laboratories, please visit www.galsonlabs.com

Centric Medical Communications

Centric Medical Communications, Inc. is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

All Care Visiting Nurse Association Of Greater Lynn Inc

All Care Visiting Nurse Association Of Greater Lynn Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lynn, MA. To find more information about All Care Visiting Nurse Association Of Greater Lynn Inc, please visit www.allcarevna.org

Med MatRx

Med MatRx is a Monaca, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.